Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_provenance.
- NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_provenance.
- NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_assertion evidence source_evidence_literature NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_provenance.
- NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_assertion SIO_000772 23233573 NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_provenance.
- NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_assertion wasDerivedFrom befree-20140225 NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_provenance.
- NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_assertion wasGeneratedBy ECO_0000203 NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_provenance.